PD-L1 surface expression on tumor cells was also discovered to suppress the cytolytic effector functions of CD8+ T cells, with additional speculation that PD-1/PD-L1 blockade could serve as an effective strategy to combat tumor cell escape [92]. The gene discussed is PDCD1; the disease is neoplasm.